Could a simple Vitamin-Like injection cut anemia drug doses for dialysis patients?

NCT ID NCT07160452

First seen Sep 30, 2025 · Last updated May 09, 2026 · Updated 23 times

Summary

This study looks at whether adding levocarnitine (a substance often low in dialysis patients) to standard care can reduce the amount of anemia medication needed. About 94 adults on long-term dialysis will receive either levocarnitine injections after each session or usual care alone for 6 months. The goal is to see if levocarnitine helps maintain healthy red blood cells with lower drug doses, potentially easing treatment burden and side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.